Kooistra Leonie A, van den Berg Jan Willem K, Patberg K W
Isala Zwolle, afd. Longgeneeskunde, Zwolle.
Contact: Leonie A. Kooistra (
Ned Tijdschr Geneeskd. 2021 Oct 21;165:D6100.
Cough is a physiological defense mechanism. However, excessive cough is known to have a great impact on quality of life. Cough is considered to be chronic when it lasts longer than 8 weeks. In the Netherlands, the prevalence is 10.9%. The concept as a whole is called 'cough hypersensitivity' in which there is a hypersensitivity of the cough reflex to aspecific stimuli. Specific treatment of the phenotype is important. If no specific phenotype is found it is called 'unexplained chronic cough' (UCC) and if symptoms persist despite treatment it is called 'chronic refractory cough' (CRC). Neuromodulating drugs are the main treatment in CRC. However, a suitable condition often cannot be achieved because of severe side effect and great interindividual variability in pharmacokinetics. New drugs, P2X3-antagonists, are being developed. These drugs mediate in a late phase of the cough reflex and are thereby considered to have fewer side effects.
咳嗽是一种生理防御机制。然而,过度咳嗽已知会对生活质量产生重大影响。咳嗽持续超过8周时被认为是慢性咳嗽。在荷兰,其患病率为10.9%。整个概念被称为“咳嗽高敏反应”,其中咳嗽反射对特定刺激存在高敏反应。对该表型进行特异性治疗很重要。如果未发现特定表型,则称为“不明原因慢性咳嗽”(UCC),如果尽管进行了治疗症状仍持续存在,则称为“慢性难治性咳嗽”(CRC)。神经调节药物是CRC的主要治疗方法。然而,由于严重的副作用和药代动力学方面巨大的个体差异,往往无法达到合适的治疗效果。新型药物P2X3拮抗剂正在研发中。这些药物在咳嗽反射的后期起作用,因此被认为副作用较少。